Journal article
Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1
JA Janusz, BP Klein-Tasman, JM Payne, PL Wolters, HL Thompson, S Martin, P De Blank, N Ullrich, A Del Castillo, M Hussey, KK Hardy, K Haebich, T Rosser, MA Toledo-Tamula, KS Walsh
Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2021
Abstract
Objective: To review parent-report social skills measures to identify and recommend consensus outcomes for use in clinical trials of social deficit in children and adolescents (ages 6-18 years) with neurofibromatosis type 1 (NF1). Methods: Searches were conducted via PubMed and ClinicalTrials.gov to identity social skills outcome measures with English language versions used in clinical trials in the past 5 years with populations with known social skills deficits, including attention-deficit/hyperactivity disorder and autism spectrum disorder (ASD). Measures were rated by the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) Neurocognitive Committee on patient characteristi..
View full abstractGrants
Funding Acknowledgements
The authors acknowledge the support of the Children & apos;s Tumor Foundation for the REiNS International Collaboration.